168 - Impact of Artificial Lipofuscin on β-Cell Functionality

Abstract

Aging is a multi-causal irreversible process characterized by a progressive degeneration affecting all higher organisms. The formation of insoluble protein aggregates such as lipofuscin is one typical hallmark of aging. The accumulation of lipofuscin has already been shown in many different tissues, but especially long-living and postmitotic cells such as neurons and skeletal muscle cells are affected by the intralysosomal accumulation of this protein aggregate. Lipofuscin can neither be degraded by lysosomal enzymes nor exocytosed, furthermore postmitotic cells are not able to protect themselves from lipofuscin accumulation by cell division. Lipofuscin is a source of reactive oxygen species, able to inhibit proteolytic systems leading to a decline in proteasomal activity. Therefore, lipofuscin is an important contributor limiting the lifespan of especially postmitotic cells. Pancreatic β-cells are also considered to be long-living cells in adults and it was shown, that these cells are characterized by an age-dependent increase in lipofuscin content. However, even though β-cell replication is a rare event in aged humans and mice, little is known about the accumulation of protein aggregates and the intracellular effects of lipofuscin in β-cells. Therefore the pancreatic β-cell line MIN6 was treated with artificial lipofuscin to investigate the impact of this aggregate on the insulin-degrading enzyme (IDE) and different parameters of β-cell functionality. Interestingly, we observed a significant rise in insulin secretion and insulin content in the aggregate-fed MIN6 cells. While the expression of insulin does not seem to be affected by lipofuscin treatment, the prescence of lipofuscin is able to decrease the activity of IDE by an unknown mechanism.